TIMP2 and acute kidney injury: Our results showed that combining u[TIMP-2]*[IGFBP7] with uKIM-1 could further improve the prediction of septic AKI progression compared to single biomarker prediction, which was also true for predicting AKI progression with death, suggesting that carefully selecting and combining biomarkers might be a better approach for greater application.